Title |
Antispasmodics for labour
|
---|---|
Published in |
Cochrane database of systematic reviews, June 2013
|
DOI | 10.1002/14651858.cd009243.pub3 |
Pubmed ID | |
Authors |
Anke C Rohwer, Oswell Khondowe, Taryn Young |
Abstract |
Prolonged labour can lead to increased maternal and neonatal mortality and morbidity due to increased risks of maternal exhaustion, postpartum haemorrhage and sepsis, fetal distress and asphyxia and requires early detection and appropriate clinical response. The risks for complications of prolonged labour are much greater in poor resource settings. Active management of labour versus physiological, expectant management, has shown to decrease the occurrence of prolonged labour. Administering antispasmodics during labour could also lead to faster and more effective dilatation of the cervix. Interventions to shorten labour, such as antispasmodics, can be used as a preventative or a treatment strategy in order to decrease the incidence of prolonged labour. As the evidence to support this is still largely anecdotal around the world, there is a need to systematically review the available evidence to obtain a valid answer. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Mexico | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 1 | <1% |
Peru | 1 | <1% |
Canada | 1 | <1% |
Unknown | 254 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 34 | 13% |
Researcher | 30 | 12% |
Student > Master | 30 | 12% |
Student > Ph. D. Student | 23 | 9% |
Student > Postgraduate | 20 | 8% |
Other | 50 | 19% |
Unknown | 70 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 96 | 37% |
Nursing and Health Professions | 35 | 14% |
Psychology | 16 | 6% |
Social Sciences | 11 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 2% |
Other | 19 | 7% |
Unknown | 74 | 29% |